China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...
Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...
ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...
Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...
After Zhejiang Huahai Pharmaceutical’s tainted valsartan API and Changchun Changsheng Life Sciences’ fabricated vaccine production data exposé, China’s drug industry could be dealing with another ...
The Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results